"OnSite Clinical Solutions, LLC is a research company that works with local physicians to connect patients with Phase I-IV clinical trial opportunities. We are dedicated to you and all your research needs."

During the past decade, Onsite Clinical Solutions, LLC conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 18 clinical trials were completed, i.e. on average, 41.9% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 15 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Onsite Clinical Solutions, LLC" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Allergan" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Aquestive Therapeutics" with 4 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onsite Clinical Solutions, LLC" #1 collaborator was "Covance" with 3 trials as a collaborator, "Dermira, Inc." with 3 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator and "Abond CRO Inc." with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Onsite Clinical Solutions, LLC" are "Cerebral Palsy" (4 trials), "Epilepsy" (4 trials), "Muscle Spasticity" (4 trials), "Pediatrics" (4 trials) and "Atopic Dermatitis" (3 trials). Many other conditions were trialed in "Onsite Clinical Solutions, LLC" in a lesser frequency.

Most popular intervention types in "Onsite Clinical Solutions, LLC" are "Drug" (39 trials), "Biological" (11 trials), "Other" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Baloxavir Marboxil" (3 trials), "Lebrikizumab" (3 trials), "Botulinum Toxin Type A" (2 trials) and "Eptinezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Onsite Clinical Solutions, LLC" are 45 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Onsite Clinical Solutions, LLC". undefined are not yet recruiting, 15 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Onsite Clinical Solutions, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Onsite Clinical Solutions, LLC, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".